kanamycin a has been researched along with phlorhizin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Jiang, M; Karasawa, T; Koo, JW; Li, H; Steyger, PS; Wang, Q | 1 |
2 other study(ies) available for kanamycin a and phlorhizin
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Sodium-glucose transporter-2 (SGLT2; SLC5A2) enhances cellular uptake of aminoglycosides.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Anti-Bacterial Agents; Biological Transport; Cell Line; Cochlea; Deoxyglucose; Female; Fluorescent Dyes; Gene Expression; Gentamicins; Hearing Tests; Kanamycin; Kidney Tubules, Distal; Kidney Tubules, Proximal; Kinetics; Male; Mice; Mice, Transgenic; Organ Specificity; Phlorhizin; RNA, Small Interfering; Sodium; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2014 |